VPS70 is referenced in yeast (Saccharomyces cerevisiae) studies as a potential protease involved in vacuolar protein sorting and secretory pathway regulation. Key findings include:
Role in Secretion Enhancement: Disruption of VPS70 in ∆ypt7 and ∆vam6 yeast strains (defective in HOPS complex subunits) further improved secretion efficiency of recombinant proteins like carboxylesterase (CES) and HyHEL-Fab .
Protease Activity: VPS70 is hypothesized to contribute to vacuolar proteolysis, as its deletion reduced degradation of secreted proteins when combined with vacuolar protease Pep4 .
The table below summarizes experimental observations from yeast studies involving VPS70 disruption:
Validation Protocols: Standardized assays for Western blot (WB), immunoprecipitation (IP), and immunofluorescence (IF) using knockout cell lines, as demonstrated for hVPS35 antibodies .
Commercial Antibody Gaps: While multiple antibodies for retromer complex proteins (e.g., VPS35) are commercially available and validated , no equivalent resources were identified for VPS70 in the reviewed literature.
The absence of VPS70 antibody data highlights a gap in current proteomic tools. Future studies could adopt the following framework:
Antibody Generation: Develop monoclonal or polyclonal antibodies using recombinant VPS70 protein.
Validation Pipeline:
WB: Compare signals in wild-type vs. VPS70 knockout yeast or mammalian cell lines.
IP: Assess ability to immunoprecipitate VPS70 from cell lysates.
Localization: Use immunofluorescence to confirm subcellular distribution (e.g., vacuolar/endosomal compartments).
KEGG: sce:YJR126C
STRING: 4932.YJR126C
VPS70 (Vacuolar Protein Sorting 70) is a potential protease involved in the vacuolar protein sorting pathway in yeast. It plays a significant role in protein trafficking and secretion mechanisms. Studies have shown that disruption of VPS70 in certain yeast strains (particularly Δypt7 and Δvam6) leads to enhanced secretion of recombinant proteins, suggesting its involvement in protein retention mechanisms . The protein is part of the complex cellular machinery that regulates protein movement between organelles, particularly affecting the trafficking between Golgi and vacuolar compartments.
VPS70 antibodies can be utilized in several research applications including:
Western blotting for detection and quantification of VPS70 protein levels
Immunoprecipitation to study protein-protein interactions
Immunofluorescence microscopy to visualize subcellular localization
Flow cytometry for detecting VPS70 in cell populations
For optimal results in these applications, researchers should validate antibody specificity using knockout controls and titrate the antibody concentration specific to their experimental system, similar to protocols established for other vacuolar protein antibodies .
Validating VPS70 antibody specificity involves:
| Validation Method | Implementation | Expected Outcome |
|---|---|---|
| Knockout/Knockdown | Using VPS70-null strains or gene silencing | Absence of signal in Western blot/immunostaining |
| Overexpression | Comparing wild-type to VPS70-overexpressing cells | Increased signal intensity proportional to expression |
| Peptide competition | Pre-incubating antibody with purified VPS70 peptide | Diminished or eliminated signal |
| Cross-reactivity testing | Testing against related VPS family proteins | Signal specific only to VPS70 |
Additionally, comparing results using multiple antibodies targeting different epitopes of VPS70 can provide further validation of specificity .
VPS70 antibodies enable detailed investigation of vacuolar protein sorting by:
Allowing visualization of VPS70 relocalization during vacuolar morphogenesis
Enabling quantitative assessment of VPS70 expression levels in different genetic backgrounds
Facilitating identification of novel VPS70 interaction partners through co-immunoprecipitation
Permitting real-time tracking of VPS70 dynamics during cellular responses to stress
These capabilities are particularly valuable when studying how disruption of HOPS complex components (like Ypt7 and Vam6) affects VPS70 localization and function in protein secretion pathways .
Research has established a significant inverse correlation between VPS70 expression and recombinant protein secretion. When VPS70 is disrupted in conjunction with HOPS complex components:
| Strain Configuration | HyHEL-Fab Secretion Increase | CES Secretion Increase |
|---|---|---|
| Δypt7 | 46% | 40% |
| Δvam6 | 41% | 73% |
| Δypt7Δvps70 | 62% | Not reported |
| Δvam6Δvps70 | 68% | Not reported |
These data demonstrate that VPS70 disruption significantly enhances recombinant protein secretion, particularly when combined with mutations in HOPS complex components, suggesting VPS70 plays a role in protein retention within the cell .
To investigate VPS70's putative protease activity, researchers can:
Perform in vitro protease assays with immunoprecipitated VPS70
Use VPS70 antibodies to track protease activity in subcellular fractions
Conduct pulse-chase experiments with VPS70 antibodies to monitor substrate degradation
Employ proximity labeling techniques with VPS70 antibodies to identify potential substrates
Designing experiments that compare wild-type VPS70 to mutant versions with altered catalytic sites can further elucidate its protease mechanisms and substrate specificity .
For effective Western blotting with VPS70 antibodies:
Sample preparation:
Lyse cells in buffer containing protease inhibitors to prevent degradation
Perform subcellular fractionation if studying VPS70 in specific compartments
Electrophoresis and transfer:
Use 10-12% SDS-PAGE gels for optimal separation
Transfer proteins to PVDF membranes at 100V for 1 hour in cold conditions
Antibody incubation:
Block membranes with 5% non-fat milk or BSA for 1 hour
Incubate with primary VPS70 antibody (1:500-1:2000 dilution) overnight at 4°C
Wash thoroughly and incubate with appropriate secondary antibody
Detection:
For optimal immunofluorescence results:
| Parameter | Recommendation | Rationale |
|---|---|---|
| Fixation | 4% paraformaldehyde (10 minutes) | Preserves protein structure while maintaining antigenicity |
| Permeabilization | 0.1% Triton X-100 (5 minutes) | Allows antibody access while preserving vacuolar structures |
| Blocking | 3% BSA in PBS (30 minutes) | Reduces non-specific binding |
| Primary antibody | 1:100-1:500 dilution (overnight, 4°C) | Balances signal strength with specificity |
| Secondary antibody | Species-appropriate fluorophore-conjugated (1:500, 1 hour, RT) | Enables visualization while minimizing background |
| Counterstaining | DAPI for nuclei; FM4-64 for vacuolar membranes | Provides context for VPS70 localization |
These parameters should be optimized for specific experimental conditions and cell types .
When encountering non-specific binding:
Increase blocking duration and concentration (try 5% BSA or 10% normal serum)
Perform more stringent washing (add 0.1% Tween-20 to wash buffers)
Titrate antibody concentration to determine optimal signal-to-noise ratio
Pre-absorb antibody with cell lysate from VPS70-null cells
Ensure appropriate negative controls are included in each experiment
Consider using monoclonal antibodies if polyclonal antibodies show excessive cross-reactivity
Careful validation using knockout controls remains the gold standard for confirming binding specificity .
When comparing antibody-based studies with genetic disruption experiments:
Antibody detection reveals protein presence but not necessarily activity
Genetic disruption studies show functional consequences but may trigger compensatory mechanisms
Discrepancies between protein detection and genetic phenotypes may indicate:
Post-translational regulation
Functional redundancy
Context-dependent activity
Technical limitations in antibody sensitivity
Researchers should integrate data from multiple approaches, including genomic, proteomic, and functional studies. For example, the enhanced secretion phenotype in Δvps70 mutants provides functional evidence that should be correlated with protein expression patterns detected by antibodies .
Combining VPS70 antibodies with antibodies against other HOPS components enables:
Multiplexed detection of protein complexes via co-immunoprecipitation
Visualization of co-localization patterns through multi-color immunofluorescence
Sequential immunoprecipitation to isolate specific subcomplexes
Analysis of stoichiometric relationships within protein assemblies
This approach is particularly valuable when studying how disruption of one HOPS component (e.g., Ypt7 or Vam6) affects the localization and function of VPS70 and other interacting proteins .
Emerging technologies for VPS70 research include:
Proximity labeling techniques (BioID, APEX) using VPS70 antibodies to map protein interaction networks
Single-molecule tracking with fluorescently-labeled antibody fragments to study VPS70 dynamics
Super-resolution microscopy combined with VPS70 immunolabeling to visualize nanoscale localization
Antibody-based proteomics to identify post-translational modifications of VPS70
De novo designed antibodies using computational approaches like those described for other challenging targets
These approaches are expanding our ability to study VPS70's role in vacuolar protein sorting with unprecedented precision and detail.